<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id><journal-title>BMC Public Health</journal-title><issn pub-type="epub">1471-2458</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16207375</article-id><article-id pub-id-type="pmc">1262729</article-id><article-id pub-id-type="publisher-id">1471-2458-5-101</article-id><article-id pub-id-type="doi">10.1186/1471-2458-5-101</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Case management for the treatment of patients with major depression in general practices – rationale, design and conduct of a cluster randomized controlled trial – PRoMPT (Primary care Monitoring for depressive Patient's Trial) [ISRCTN66386086] – Study protocol</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Gensichen</surname><given-names>Jochen</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>gensichen@allgemeinmedizin.uni-frankfurt.de</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Torge</surname><given-names>Marion</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>torge@allgemeinmedizin.uni-frankfurt.de</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Peitz</surname><given-names>Monika</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>peitz@allgemeinmedizin.uni-frankfurt.de</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Wendt-Hermainski</surname><given-names>Heike</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>wendt-hermainski@allgemeinmedizin.uni-frankfurt.de</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Beyer</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>beyer@allgemeinmedizin.uni-frankfurt.de</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Rosemann</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>Thomas.Rosemann@med.uni-heidelberg.de</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Krauth</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>krauth.christian@mh-hannover.de</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Raspe</surname><given-names>Heiner</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>heiner.raspe@sozmed.uni-luebeck.de</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Aldenhoff</surname><given-names>Josef B</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>aldenhoff@psychiatry.uni-kiel.de</email></contrib><contrib id="A10" contrib-type="author"><name><surname>Gerlach</surname><given-names>Ferdinand M</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>gerlach@allgemeinmedizin.uni-frankfurt.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Institute for General Practice, Chronic Care and Health Services Research University of Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt a. M., Germany</aff><aff id="I2"><label>2</label>Department of General Practice and Health Services Research, University of Heidelberg, Voβbstr. 2, 69115 Heidelberg, Germany</aff><aff id="I3"><label>3</label>Department of Epidemiology, Social Medicine and Health System Research, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany</aff><aff id="I4"><label>4</label>Institute for Social Medicine, University of Lübeck, Beckergrube 43-47, 23552 Lübeck, Germany</aff><aff id="I5"><label>5</label>Center for Integrative Psychiatry – University Hospital Schleswig-Holstein – Campus Kiel, Niemannsweg 147, 24105 Kiel, Germany</aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>5</day><month>10</month><year>2005</year></pub-date><volume>5</volume><fpage>101</fpage><lpage>101</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2458/5/101"></ext-link><history><date date-type="received"><day>5</day><month>8</month><year>2005</year></date><date date-type="accepted"><day>5</day><month>10</month><year>2005</year></date></history><permissions><copyright-statement>Copyright © 2005 Gensichen et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>Gensichen et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="5249" xml_f="5259" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="5270" xml_f="5815" txt_i="22" txt_f="567">Depression is a disorder with high prevalence in primary health care and a significant burden of illness. The delivery of health care for depression, as well as other chronic illnesses, has been criticized for several reasons and new strategies to address the needs of these illnesses have been advocated. Case management is a patient-centered approach which has shown efficacy in the treatment of depression in highly organized Health Maintenance Organization (HMO) settings and which might also be effective in other, less structured settings.</offsets></p></sec><sec><title><offsets xml_i="5837" xml_f="5851" txt_i="569" txt_f="583">Methods/Design</offsets></title><p><offsets xml_i="5862" xml_f="7210" txt_i="584" txt_f="1932">PRoMPT (PRimary care Monitoring for depressive Patients Trial) is a cluster randomised controlled trial with General Practice (GP) as the unit of randomisation. The aim of the study is to evaluate a GP applied case-management for patients with major depressive disorder. 70 GPs were randomised either to intervention group or to control group with the control group delivering usual care. Each GP will include 10 patients suffering from major depressive disorder according to the DSM-IV criteria. The intervention group will receive treatment based on standardized guidelines and monthly telephone monitoring from a trained practice nurse. The nurse investigates the patient's status concerning the MDD criteria, his adherence to GPs prescriptions, possible side effects of medication, and treatment goal attainment. The control group receives usual care – including recommended guidelines. Main outcome measure is the cumulative score of the section depressive disorders (PHQ-9) from the German version of the Prime MD Patient Health Questionnaire (PHQ-D). Secondary outcome measures are the Beck-Depression-Inventory, self-reported adherence (adapted from Moriskey) and the SF-36. In addition, data are collected about patients' satisfaction (EUROPEP-tool), medication, health care utilization, comorbidity, suicide attempts and days out of work.</offsets></p><p><offsets xml_i="7217" xml_f="7342" txt_i="1933" txt_f="2058">The study comprises three assessment times: baseline (T0) , follow-up after 6 months (T1) and follow-up after 12 months (T2).</offsets></p></sec><sec><title><offsets xml_i="7364" xml_f="7374" txt_i="2060" txt_f="2070">Discussion</offsets></title><p><offsets xml_i="7385" xml_f="7817" txt_i="2071" txt_f="2503">Depression is now recognized as a disorder with a high prevalence in primary care but with insufficient treatment response. Case management seems to be a promising intervention which has the potential to bridge the gap of the usually time-limited and fragmented provision of care. Case management has been proven to be effective in several studies but its application in the private general medical practice setting remains unclear.</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="7879" xml_f="7889" txt_i="2512" txt_f="2522">Background</offsets></title><p><offsets xml_i="7900" xml_f="7947" txt_i="2523" txt_f="2570">Depression is a significant burden of illness [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="7978" xml_f="7979" txt_i="2570" txt_f="2571">1</offsets></xref><offsets xml_i="7986" xml_f="7987" txt_i="2571" txt_f="2572">,</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="8018" xml_f="8019" txt_i="2572" txt_f="2573">2</offsets></xref><offsets xml_i="8026" xml_f="8105" txt_i="2573" txt_f="2652">]. Most depressed patients are diagnosed and treated by general practitioners [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="8136" xml_f="8137" txt_i="2652" txt_f="2653">3</offsets></xref><offsets xml_i="8144" xml_f="8145" txt_i="2653" txt_f="2654">,</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="8176" xml_f="8177" txt_i="2654" txt_f="2655">4</offsets></xref><offsets xml_i="8184" xml_f="8263" txt_i="2655" txt_f="2734">]. Depression is the third most common reason for a primary care consultation [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="8294" xml_f="8295" txt_i="2734" txt_f="2735">5</offsets></xref><offsets xml_i="8302" xml_f="8417" txt_i="2735" txt_f="2850">]. Patients with depression account for 50% higher health care costs patients than patients who are not depressed [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="8448" xml_f="8449" txt_i="2850" txt_f="2851">6</offsets></xref><offsets xml_i="8456" xml_f="8697" txt_i="2851" txt_f="3092">]. When improving primary health care for chronic conditions, a number of problems have to be resolved: discontinuity and fragmentation of the process of care, lack of co-ordination between different providers, and "the tyranny of urgency" [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="8728" xml_f="8729" txt_i="3092" txt_f="3093">7</offsets></xref><offsets xml_i="8736" xml_f="8921" txt_i="3093" txt_f="3278">]. In the management of depression, these deficits lead to frequent interruption or premature termination of drug therapy, which increases the risk of unfavourable depression outcomes [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="8952" xml_f="8953" txt_i="3278" txt_f="3279">8</offsets></xref><offsets xml_i="8960" xml_f="8961" txt_i="3279" txt_f="3280">,</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="8992" xml_f="8993" txt_i="3280" txt_f="3281">9</offsets></xref><offsets xml_i="9000" xml_f="9101" txt_i="3281" txt_f="3382">]. Patient-centred approaches with a focus on empowerment and self management have been recommended [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="9133" xml_f="9135" txt_i="3382" txt_f="3384">10</offsets></xref><offsets xml_i="9142" xml_f="9143" txt_i="3384" txt_f="3385">,</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="9174" xml_f="9175" txt_i="3385" txt_f="3386">7</offsets></xref><offsets xml_i="9182" xml_f="9183" txt_i="3386" txt_f="3387">,</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="9215" xml_f="9217" txt_i="3387" txt_f="3389">11</offsets></xref><offsets xml_i="9224" xml_f="9646" txt_i="3389" txt_f="3811">]. Case Management may be one approach to improve depression care. Case Management has been defined as "taking responsibility for following-up patients; determining whether patients were continuing the prescribed treatment as intended; assessing whether depressive symptoms were improving; and taking action when patients were not adhering to guideline based treatment or when they were not showing expected improvement" [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="9678" xml_f="9680" txt_i="3811" txt_f="3813">12</offsets></xref><offsets xml_i="9687" xml_f="9989" txt_i="3813" txt_f="4115">]. Case Management consists of five essential components: (1) identification of patients in need of services, (2) assessment of individual patient needs, (3) developing a treatment plan, (4) coordination of care, and (5) monitoring outcomes and altering care when favourable outcomes are not achieved [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="10021" xml_f="10023" txt_i="4115" txt_f="4117">13</offsets></xref><offsets xml_i="10030" xml_f="10032" txt_i="4117" txt_f="4119">].</offsets></p><p><offsets xml_i="10039" xml_f="10179" txt_i="4120" txt_f="4260">Reviews of controlled trials including our meta-analysis concluded that Case Management improves patient outcomes – with a moderate effect [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="10211" xml_f="10213" txt_i="4260" txt_f="4262">12</offsets></xref><offsets xml_i="10220" xml_f="10221" txt_i="4262" txt_f="4263">,</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="10253" xml_f="10255" txt_i="4263" txt_f="4265">14</offsets></xref><offsets xml_i="10262" xml_f="10263" txt_i="4265" txt_f="4266">,</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="10295" xml_f="10297" txt_i="4266" txt_f="4268">15</offsets></xref><offsets xml_i="10304" xml_f="10648" txt_i="4268" txt_f="4612">]. However, most of the studies available were conducted in highly organized Health Maintenance Organizations (HMO) setting using central based stuff to run the intervention. However, it still remains unclear what the effects in a peripheral setting as a private general practice based case management for patients with depression will be like.</offsets></p></sec><sec><title><offsets xml_i="10670" xml_f="10684" txt_i="4614" txt_f="4628">Methods/Design</offsets></title><sec><title><offsets xml_i="10704" xml_f="10720" txt_i="4629" txt_f="4645">Aim of the study</offsets></title><p><offsets xml_i="10731" xml_f="10835" txt_i="4646" txt_f="4750">The study examines the efficacy of a GP based case management intervention for patients with depression.</offsets></p></sec><sec><title><offsets xml_i="10857" xml_f="10878" txt_i="4752" txt_f="4773">Scientific hypothesis</offsets></title><p><offsets xml_i="10889" xml_f="11122" txt_i="4774" txt_f="5007">Case management (intervention) leads to greater reductions in depressive symptoms than usual care (control group). We hypothesize further that case management leads to a greater increase in adherence (medication) and quality of life.</offsets></p></sec><sec><title><offsets xml_i="11144" xml_f="11156" txt_i="5009" txt_f="5021">Study design</offsets></title><p><offsets xml_i="11167" xml_f="11509" txt_i="5022" txt_f="5364">The study is a (prospective) cluster-randomized two-armed intervention study with the practices being clusters. The design of a cluster randomized study was chosen because with this type of study internal validity (absence of confounders) can be optimized, contamination of interventions associated with patient randomization is not possible.</offsets></p></sec><sec><title><offsets xml_i="11531" xml_f="11542" txt_i="5366" txt_f="5377">Sample size</offsets></title><p><offsets xml_i="11553" xml_f="11673" txt_i="5378" txt_f="5498">Sample size calculations for cluster randomized trials differ completely from sample size calculations for common RCTs [</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="11705" xml_f="11707" txt_i="5498" txt_f="5500">16</offsets></xref><offsets xml_i="11714" xml_f="11715" txt_i="5500" txt_f="5501">,</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="11747" xml_f="11749" txt_i="5501" txt_f="5503">17</offsets></xref><offsets xml_i="11756" xml_f="11871" txt_i="5503" txt_f="5618">]. Based on the main outcome parameter depression symptom and the main outcome-assessment instrument (GERMAN-PHQ) [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="11903" xml_f="11905" txt_i="5618" txt_f="5620">18</offsets></xref><offsets xml_i="11912" xml_f="11985" txt_i="5620" txt_f="5693">] we performed a power calculation with the method of Hayes and Bennett [</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="12017" xml_f="12019" txt_i="5693" txt_f="5695">19</offsets></xref><offsets xml_i="12026" xml_f="12332" txt_i="5695" txt_f="6001">]. It is provided to record a clinical relevant intervention effect of the Case Management from yet 10% up to the primary size, thus an improvement of the depression score (PHQ-D). Assuming an effect of 35 % (PHQ – Score difference from 18,6 to 12.9) in intervention group and a effect of 25 % in control [</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="12364" xml_f="12366" txt_i="6001" txt_f="6003">20</offsets></xref><offsets xml_i="12373" xml_f="12629" txt_i="6003" txt_f="6259">] (PHQ Score – 18.6 to 12.9) we have to detect a minimal difference of 1,86. With an alpha of 5%, a beta of 20%, a SD of 6.1 and a ICC 0.1 we are calculating N = 680 (drop-out 30% included). Every arm of the study (34 practices) has to include 10 Patients.</offsets></p></sec><sec><title><offsets xml_i="12651" xml_f="12687" txt_i="6261" txt_f="6297">Recruitment of GPs and randomization</offsets></title><p><offsets xml_i="12698" xml_f="13741" txt_i="6298" txt_f="7341">As described above, the GPs form the unit of randomization (cluster). It was decided to address and to include only those practices that have a contract with all German insurances, because 90 % of care provision is covered by this type of practices. About 1600 GPs in the city of Frankfurt and the region near by (federal state of Hessen) were informed by mail about the study and invited to a meeting. After this meeting, 72 GPs gave their written consent to participate in the study. Based on detailed information about the practice and the GP, the inclusion criteria were checked (no exclusive clinical specialization) and two practices had to be excluded due to the inclusion criteria. The 70 GPs were stratified according to the size of the city where the practice is located and then randomized to the intervention group or the control group. The procedure was done by an independent assistant who is not familiar to one of the participating doctors and is not a person of the project team. A randomization protocol was written. (Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="13771" xml_f="13772" txt_i="7341" txt_f="7342">1</offsets></xref><offsets xml_i="13779" xml_f="13780" txt_i="7342" txt_f="7343">)</offsets></p><fig position="float" id="F1"><label><offsets xml_i="13821" xml_f="13829" txt_i="7344" txt_f="7352">Figure 1</offsets></label><graphic xlink:href="1471-2458-5-101-1"></graphic></fig></sec><sec><title><offsets xml_i="13911" xml_f="13942" txt_i="7353" txt_f="7384">Case manager inclusion criteria</offsets></title><p><offsets xml_i="13953" xml_f="14219" txt_i="7385" txt_f="7651">For the practice nurses who wanted to engage in the study, the following criteria are recommended: formal training as practice nurse and at least one year work experience after completion of formal training, and participation in the study case management work shops.</offsets></p></sec><sec><title><offsets xml_i="14241" xml_f="14267" txt_i="7653" txt_f="7679">Patient inclusion criteria</offsets></title><p><offsets xml_i="14278" xml_f="14618" txt_i="7680" txt_f="8020">Adult Patients, diagnosed with a Major Depression Episode, aged from 18 to 80 years, capability to give informed consent, sufficient knowledge of the German language and indication for antidepressive treatment (medication and/or psychotherapy) can be included. Diagnostic procedure consists in self-report of depressive symptoms via PHQ-9 [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="14650" xml_f="14652" txt_i="8020" txt_f="8022">18</offsets></xref><offsets xml_i="14659" xml_f="15174" txt_i="8022" txt_f="8537">] and subsequent validation in a clinical interview. Participating practices keep an alphabetic record of their patients who are already on treatment. Five Patients from this list are contacted in consecutive order of appearance in the practice and informed about the option to participate in the study. After checking the inclusion criteria and receiving the informed consent, patients receive the questionnaires. Afterwards, five new patients, fulfilling the same criteria, are to be recruited on a screening-day.</offsets></p></sec><sec><title><offsets xml_i="15196" xml_f="15211" txt_i="8539" txt_f="8554">Data collection</offsets></title><p><offsets xml_i="15222" xml_f="15924" txt_i="8555" txt_f="9257">After giving their informed and written consent to participate in the study patients will receive the questionnaires. The completed questionnaires will be turned back to the practice where there a collected from a member of the project team when the practice has recruited 10 patients. The envelopes are opened at the university and scanned ("eyes and hands ™ FORMS "-Software, Version 5-2 of Read Soft). A TIF-file is generated out of each questionnaire to avoid any data-manipulation and to have a medium for data storage. The scanned data are transferred into the SPSS files. For documentation and data reporting in publications CONSORT recommendations for cluster randomized trials are considered [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="15956" xml_f="15958" txt_i="9257" txt_f="9259">21</offsets></xref><offsets xml_i="15965" xml_f="15967" txt_i="9259" txt_f="9261">].</offsets></p></sec><sec><title><offsets xml_i="15989" xml_f="16006" txt_i="9263" txt_f="9280">Outcome-parameter</offsets></title><p><offsets xml_i="16017" xml_f="16023" txt_i="9281" txt_f="9287">Table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="16055" xml_f="16056" txt_i="9287" txt_f="9288">1</offsets></xref><offsets xml_i="16063" xml_f="16364" txt_i="9288" txt_f="9589"> displays the outcome parameters and additionally used instruments. The primary outcome is the depression score assessed by the PHQ-9 questionnaire. The PHQ is an internationally applied instrument for the screening in primary care of the major mental disorders. The German version is also validated [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="16396" xml_f="16398" txt_i="9589" txt_f="9591">18</offsets></xref><offsets xml_i="16405" xml_f="16435" txt_i="9591" txt_f="9621">]. Secondary outcomes include:</offsets></p><table-wrap position="float" id="T1"><label><offsets xml_i="16483" xml_f="16490" txt_i="9622" txt_f="9629">Table 1</offsets></label><caption><p><offsets xml_i="16510" xml_f="16534" txt_i="9629" txt_f="9653">Outcomes and instruments</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold><offsets xml_i="16619" xml_f="16646" txt_i="9654" txt_f="9681">Outcome-Parameter (Patient)</offsets></bold></td><td align="center"><bold><offsets xml_i="16683" xml_f="16693" txt_i="9682" txt_f="9692">Instrument</offsets></bold></td></tr></thead><tbody><tr><td align="left"><bold><offsets xml_i="16752" xml_f="16767" txt_i="9693" txt_f="9708">Primary Outcome</offsets></bold></td><td></td></tr><tr><td align="left"><offsets xml_i="16814" xml_f="16824" txt_i="9710" txt_f="9720">Depression</offsets></td><td align="center"><offsets xml_i="16848" xml_f="16853" txt_i="9721" txt_f="9726">PHQ-9</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="16890" xml_f="16907" txt_i="9727" txt_f="9744">Secondary outcome</offsets></bold></td><td></td></tr><tr><td align="left"><offsets xml_i="16954" xml_f="16964" txt_i="9746" txt_f="9756">Depression</offsets></td><td align="center"><offsets xml_i="16988" xml_f="17018" txt_i="9757" txt_f="9787">BDI (Beck-Depression-Inventar)</offsets></td></tr><tr><td align="left"><offsets xml_i="17049" xml_f="17064" txt_i="9788" txt_f="9803">Quality of life</offsets></td><td align="center"><offsets xml_i="17088" xml_f="17093" txt_i="9804" txt_f="9809">SF-36</offsets></td></tr><tr><td align="left"><offsets xml_i="17124" xml_f="17147" txt_i="9810" txt_f="9833">Adherence to medication</offsets></td><td align="center"><offsets xml_i="17171" xml_f="17222" txt_i="9834" txt_f="9885">Adapted version of Moriskey adherence questionnaire</offsets></td></tr><tr><td align="left"><offsets xml_i="17253" xml_f="17276" txt_i="9886" txt_f="9909">Health care utilization</offsets></td><td align="center"><offsets xml_i="17300" xml_f="17341" txt_i="9910" txt_f="9951">questionnaire, retrospective chart review</offsets></td></tr><tr><td align="left"><offsets xml_i="17372" xml_f="17392" txt_i="9952" txt_f="9972">Patient satisfaction</offsets></td><td align="center"><offsets xml_i="17416" xml_f="17432" txt_i="9973" txt_f="9989">Modified EUROPEP</offsets></td></tr><tr><td align="left"><offsets xml_i="17463" xml_f="17479" txt_i="9990" txt_f="10006">Suicide attempts</offsets></td><td align="center"><offsets xml_i="17503" xml_f="17516" txt_i="10007" txt_f="10020">questionnaire</offsets></td></tr><tr><td align="left"><offsets xml_i="17547" xml_f="17563" txt_i="10021" txt_f="10037">Days out of work</offsets></td><td align="center"><offsets xml_i="17587" xml_f="17600" txt_i="10038" txt_f="10051">questionnaire</offsets></td></tr></tbody></table></table-wrap><p><offsets xml_i="17642" xml_f="17681" txt_i="10052" txt_f="10091">• the Beck-Depression-Inventory (BDI) [</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="17713" xml_f="17715" txt_i="10091" txt_f="10093">22</offsets></xref><offsets xml_i="17722" xml_f="17723" txt_i="10093" txt_f="10094">]</offsets></p><p><offsets xml_i="17730" xml_f="17781" txt_i="10095" txt_f="10146">• self-reported adherence (adapted from Moriskey) [</offsets><xref ref-type="bibr" rid="B23"><offsets xml_i="17813" xml_f="17815" txt_i="10146" txt_f="10148">23</offsets></xref><offsets xml_i="17822" xml_f="17823" txt_i="10148" txt_f="10149">]</offsets></p><p><offsets xml_i="17830" xml_f="17857" txt_i="10150" txt_f="10177">• Quality of life (SF-36) [</offsets><xref ref-type="bibr" rid="B24"><offsets xml_i="17889" xml_f="17891" txt_i="10177" txt_f="10179">24</offsets></xref><offsets xml_i="17898" xml_f="17899" txt_i="10179" txt_f="10180">]</offsets></p><p><offsets xml_i="17906" xml_f="18010" txt_i="10181" txt_f="10285">• Health Care utilization (referrals to specialists, days in clinic); data retrieved form patients chart</offsets></p><p><offsets xml_i="18017" xml_f="18074" txt_i="10286" txt_f="10343">• Patient satisfaction (modified EUROPEP-questionnaire) [</offsets><xref ref-type="bibr" rid="B25"><offsets xml_i="18106" xml_f="18108" txt_i="10343" txt_f="10345">25</offsets></xref><offsets xml_i="18115" xml_f="18116" txt_i="10345" txt_f="10346">]</offsets></p><p><offsets xml_i="18123" xml_f="18141" txt_i="10347" txt_f="10365">• Suicide attempts</offsets></p><p><offsets xml_i="18148" xml_f="18166" txt_i="10366" txt_f="10384">• Days out of work</offsets></p><p><offsets xml_i="18173" xml_f="18451" txt_i="10385" txt_f="10663">These data will be compiled from patient questionnaires and patients chart review. All instruments are well validated and frequently used in international studies. Assessments are done three times: baseline (T0), follow-up after 6 months (T1) and follow up after 12 months (T2).</offsets></p></sec><sec><title><offsets xml_i="18473" xml_f="18485" txt_i="10665" txt_f="10677">Intervention</offsets></title><p><offsets xml_i="18496" xml_f="18915" txt_i="10678" txt_f="11097">The practice nurses of the intervention group will be trained to case manager in two work-shops with the following contents: main features of the disorder, communication skills, telephone monitoring and documentation. A follow-up work-shop is scheduled to supervise the telephone-monitoring, and each practice is contacted bimonthly from the project team to advice concerning assessment, documentation and intervention.</offsets></p><p><offsets xml_i="18922" xml_f="18971" txt_i="11098" txt_f="11147">The intervention comprises the following aspects:</offsets></p><p><offsets xml_i="18978" xml_f="19378" txt_i="11148" txt_f="11548">1. The case manager begins with an introduction session which aims at establishing contact, explaining the patient his/her function, delivering information about the disorder and the self-management tools (education). GPs will also receive a written patient leaflet which provides information about the cause and the treatment possibilities as well as coping strategies and a list of self help books.</offsets></p><p><offsets xml_i="19385" xml_f="19761" txt_i="11549" txt_f="11925">2. The case manager contacts the patient for telephone monitoring (10–15 minutes). Based on a structured interview, the case manager will ask the patient first two-weekly (the first two months) and than in intervals of 4 weeks about the status of depression, adherence, side effects of medication and goal-attainment (Depression Monitoring List – DeMol, Gensichen unpublished)</offsets></p><p><offsets xml_i="19768" xml_f="19849" txt_i="11926" txt_f="12007">3. After each patient contact, a short report will be given to the family doctor.</offsets></p><p><offsets xml_i="19856" xml_f="20123" txt_i="12008" txt_f="12275">In both the intervention and the control group, GPs will receive a summary of evidence based treatments of depression in a primary care setting and these information contain amongst others, the NHG guidelines. There is no implementation strategy in the control group.</offsets></p></sec><sec><title><offsets xml_i="20145" xml_f="20167" txt_i="12277" txt_f="12299">Timeframe of the study</offsets></title><p><offsets xml_i="20178" xml_f="20462" txt_i="12300" txt_f="12584">The study team has already randomized the 70 GPs who have declared their willingness to participate in the study and who accepted random assignment to the different groups. The study protocol was approved by the ethics commission of the University of Frankfurt (Approval-Nr. E 26/05).</offsets></p><p><offsets xml_i="20469" xml_f="20592" txt_i="12585" txt_f="12708">The patient enrollment has already started and up to now, about 220 patient are included who completed baseline assessment.</offsets></p></sec><sec><title><offsets xml_i="20614" xml_f="20634" txt_i="12710" txt_f="12730">Description of risks</offsets></title><p><offsets xml_i="20645" xml_f="20812" txt_i="12731" txt_f="12898">To our knowledge, serious risks or undesired effects of completing questionnaires are not reported in the literature. There are no specific risks related to the study.</offsets></p></sec><sec><title><offsets xml_i="20834" xml_f="20852" txt_i="12900" txt_f="12918">Ethical principles</offsets></title><p><offsets xml_i="20863" xml_f="21036" txt_i="12919" txt_f="13092">The study is planned and conducted in accordance with medical professional codex and the Helsinki Declaration of 1996 as well as the German Federal Data Security Law (BDSG).</offsets></p><p><offsets xml_i="21043" xml_f="21274" txt_i="13093" txt_f="13324">Patients participate in the study voluntarily. They are informed that they can cancel at any time their participation without disclosing reasons for their cancellation and without negative consequences to their future medical care.</offsets></p></sec><sec><title><offsets xml_i="21296" xml_f="21320" txt_i="13326" txt_f="13350">Patient informed consent</offsets></title><p><offsets xml_i="21331" xml_f="21599" txt_i="13351" txt_f="13619">Patients receive written and spoken information about the main features of the study; i.e. about potential benefits for their health and potential risks prior to their consent and participation in the study. In case of acceptance, they sign the informed consent sheet.</offsets></p><p><offsets xml_i="21606" xml_f="21737" txt_i="13620" txt_f="13751">In case of study discontinuation data will be extinguished, except the patient affirms explicitly the further analysis of his data.</offsets></p></sec><sec><title><offsets xml_i="21759" xml_f="21787" txt_i="13753" txt_f="13781">Vote of the ethics committee</offsets></title><p><offsets xml_i="21798" xml_f="22108" txt_i="13782" txt_f="14092">The study protocol was approved by the ethics committee of the University of Frankfurt previous to the start of the study in April 25, 2005. Inclusion of patients/participants did not start unless there was a written and unrestricted positive vote of the ethics committee. This vote was received in March 2005.</offsets></p></sec><sec><title><offsets xml_i="22130" xml_f="22176" txt_i="14094" txt_f="14140">Data security/disclosure of original documents</offsets></title><p><offsets xml_i="22187" xml_f="22431" txt_i="14141" txt_f="14385">The patient names and other confidential information are secured by the medical confidentiality rules and are treated according to German Federal Data Security Law (BDSG). The results of the patient questionnaires are not accessible to the GPs.</offsets></p><p><offsets xml_i="22438" xml_f="22619" txt_i="14386" txt_f="14567">All study related data and documents are stored on a protected central server of the Frankfurt University Clinic. Only members of the study team have access to the respective files.</offsets></p><p><offsets xml_i="22626" xml_f="22784" txt_i="14568" txt_f="14726">Intermediate and final reports are stored in the office of the Department of General Practice and Health Services Research at the Frankfurt University Clinic.</offsets></p></sec></sec><sec><title><offsets xml_i="22812" xml_f="22831" txt_i="14729" txt_f="14748">Competing interests</offsets></title><p><offsets xml_i="22842" xml_f="22902" txt_i="14749" txt_f="14809">The author(s) declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="22924" xml_f="22946" txt_i="14811" txt_f="14833">Authors' contributions</offsets></title><p><offsets xml_i="22957" xml_f="23212" txt_i="14834" txt_f="15089">JG, MT, MP and MB conceived and performed the study and draft manuscript. HWH and HR developed the data-management. CK performed health economical aspects TR, JA and FMG participated in the study design. All authors read and approved the final manuscript.</offsets></p></sec><sec><title><offsets xml_i="23234" xml_f="23257" txt_i="15091" txt_f="15114">Pre-publication history</offsets></title><p><offsets xml_i="23268" xml_f="23332" txt_i="15115" txt_f="15179">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2458/5/101/prepub"></ext-link></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This study is financed by the German Ministry of Education and Research (BMBF), grant-number DLR 01 GK 0302.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ormel</surname><given-names>J</given-names></name><name><surname>von Korff</surname><given-names>M</given-names></name><name><surname>Ustun</surname><given-names>T</given-names></name><name><surname>Pini</surname><given-names>S</given-names></name><name><surname>Korten</surname><given-names>A</given-names></name><name><surname>Oldehinkel</surname><given-names>T</given-names></name></person-group><article-title>Common mental disorders and disabilities across cultures. Results from the WHO Collaborative Primary Care Study</article-title><source>JAMA</source><year>1994</year><volume>272</volume><fpage>1741</fpage><lpage>1748</lpage><pub-id pub-id-type="pmid">7966922</pub-id><pub-id pub-id-type="doi">10.1001/jama.272.22.1741</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ormel</surname><given-names>J</given-names></name><name><surname>Oldehinkel</surname><given-names>AJ</given-names></name><name><surname>Nolen</surname><given-names>WA</given-names></name><name><surname>Vollebergh</surname><given-names>W</given-names></name></person-group><article-title>Psychosocial disability before, during and after a major depressive episode: A 3-wave population-based study of state, scar, and trait effects</article-title><source>Archives of General Psychiatry</source><year>2004</year><volume>61</volume><fpage>387</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">15066897</pub-id><pub-id pub-id-type="doi">10.1001/archpsyc.61.4.387</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamerow</surname><given-names>D</given-names></name></person-group><article-title>Research on mental health in primary care settings. Rationale, topics and support</article-title><source>Family Practice Research Journal</source><year>1986</year><volume>6</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">3455110</pub-id></citation></ref><ref id="B4"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Ustun</surname><given-names>T</given-names></name><name><surname>Sartorius</surname><given-names>N</given-names></name></person-group><source>Mental illness in general health care – an international Study</source><year>1995</year><publisher-name>John Wiley &amp; Sons: Chichester</publisher-name></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>A</given-names></name></person-group><article-title>The burden of psychiatric disorder in primary care</article-title><source>International Review of Psychiatry</source><year>1992</year><volume>4</volume><fpage>243</fpage><lpage>250</lpage></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>G</given-names></name><name><surname>Ormel</surname><given-names>J</given-names></name></person-group><article-title>Health care costs associated with depression and anxiety disorders in primary care</article-title><source>Archives General Psychiatry</source><year>1995</year><volume>52</volume><fpage>850</fpage><lpage>856</lpage></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bodenheimer</surname><given-names>T</given-names></name><name><surname>Wagner</surname><given-names>E</given-names></name><name><surname>Grumbach</surname><given-names>K</given-names></name></person-group><article-title>Improving primary care for patients with chronic illness – The chronic care model. Part 2</article-title><source>JAMA</source><year>2002</year><volume>288</volume><fpage>1909</fpage><lpage>1914</lpage><pub-id pub-id-type="pmid">12377092</pub-id><pub-id pub-id-type="doi">10.1001/jama.288.15.1909</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahrens</surname><given-names>B</given-names></name><name><surname>Linden</surname><given-names>M</given-names></name></person-group><article-title>[Factors of chronification for depression] Faktoren der Chronifizierung von Depressionen</article-title><source>Münchner Medizinische Wochenschrift</source><year>1991</year><volume>133</volume><fpage>49</fpage><lpage>50</lpage></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fritze</surname><given-names>J</given-names></name></person-group><article-title>[How long to prescribe antidepressants?] Wie lange sollten Antidepressiva verordnet werden?</article-title><source>Psychopharmakotherapie</source><year>1997</year><volume>5</volume><fpage>7</fpage><lpage>25</lpage></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coulter</surname><given-names>A</given-names></name><name><surname>Elwyn</surname><given-names>G</given-names></name></person-group><article-title>What do patients want from high quality general practice and how do we involve them in improvement?</article-title><source>Br J Gen Pract</source><year>2002</year><volume>52</volume><fpage>S22</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">12389766</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Os van</surname><given-names>T</given-names></name><name><surname>Ormel</surname><given-names>J</given-names></name><name><surname>Brink van den</surname><given-names>R</given-names></name><name><surname>Jenner</surname><given-names>J</given-names></name><name><surname>Meer van der</surname><given-names>K</given-names></name><name><surname>Tiemens</surname><given-names>B</given-names></name><name><surname>Doom</surname><given-names>W</given-names></name><name><surname>van der Smit</surname><given-names>A</given-names></name><name><surname>Brink van den</surname><given-names>W</given-names></name></person-group><article-title>Training primary care physicians improve the management of depression</article-title><source>General Hospital Psychiatry</source><year>1999</year><volume>21</volume><fpage>168</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">10378110</pub-id><pub-id pub-id-type="doi">10.1016/S0163-8343(98)00080-2</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Von Korff</surname><given-names>M</given-names></name><name><surname>Goldberg</surname><given-names>D</given-names></name></person-group><article-title>Improving outcomes in depression – The whole process of care needs to be enhanced</article-title><source>British Medical Journal</source><year>2001</year><volume>323</volume><fpage>948</fpage><lpage>949</lpage><pub-id pub-id-type="pmid">11679372</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norris</surname><given-names>S</given-names></name><name><surname>Nicols</surname><given-names>P</given-names></name><name><surname>Caspersen</surname><given-names>C</given-names></name><name><surname>Glasgow</surname><given-names>R</given-names></name><name><surname>Engelgau</surname><given-names>M</given-names></name><name><surname>Jack</surname><given-names>L</given-names></name><name><surname>Isham</surname><given-names>G</given-names></name><name><surname>Snyder</surname><given-names>S</given-names></name><name><surname>Carande-Kulis</surname><given-names>V</given-names></name><name><surname>Isham</surname><given-names>G</given-names></name><name><surname>Garfield</surname><given-names>S</given-names></name><name><surname>Briss</surname><given-names>P</given-names></name><name><surname>McCulloch</surname><given-names>D</given-names></name></person-group><article-title>The effectiveness of disease and case management for people with diabetes – A systematic review</article-title><source>Am J Prev Med</source><year>2002</year><volume>22</volume><fpage>15</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">11985933</pub-id><pub-id pub-id-type="doi">10.1016/S0749-3797(02)00423-3</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilbody</surname><given-names>S</given-names></name><name><surname>Whitty</surname><given-names>P</given-names></name><name><surname>Grimshaw</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name></person-group><article-title>Educational and organizational interventions to improve the management of depression in primary care: a systematic review</article-title><source>JAMA</source><year>2003</year><volume>289</volume><fpage>3145</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">12813120</pub-id><pub-id pub-id-type="doi">10.1001/jama.289.23.3145</pub-id></citation></ref><ref id="B15"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Gensichen</surname><given-names>J</given-names></name><name><surname>Beyer</surname><given-names>M</given-names></name><name><surname>Muth</surname><given-names>C</given-names></name><name><surname>Gerlach</surname><given-names>FM</given-names></name><name><surname>v Korff</surname><given-names>M</given-names></name><name><surname>Ormel</surname><given-names>H</given-names></name></person-group><article-title>Case Management to improve major depression in primary health care – a systematic review</article-title><source>Psychological Medicine</source><year>2005</year><comment>in press</comment></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>MK</given-names></name><name><surname>Grimshaw</surname><given-names>J</given-names></name><name><surname>Steen</surname><given-names>N</given-names></name></person-group><article-title>Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action)</article-title><source>J Health Serv Res Policy</source><year>2000</year><volume>5</volume><fpage>12</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">10787581</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>MK</given-names></name><name><surname>Mollison</surname><given-names>J</given-names></name><name><surname>Grimshaw</surname><given-names>JM</given-names></name></person-group><article-title>Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size</article-title><source>Stat Med</source><year>2001</year><volume>20</volume><fpage>391</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">11180309</pub-id><pub-id pub-id-type="doi">10.1002/1097-0258(20010215)20:3&lt;391::AID-SIM800&gt;3.0.CO;2-Z</pub-id></citation></ref><ref id="B18"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Löwe</surname><given-names>B</given-names></name><name><surname>Spitzer</surname><given-names>RL</given-names></name><name><surname>Zipfel</surname><given-names>L</given-names></name><name><surname>Herzog</surname><given-names>W</given-names></name></person-group><article-title>Gesundheitsfragebogen für Patienten (PHQ-D)</article-title><source>Komplettversion mit vorläufigem Manual, Fragebogen, Schablonen Pfizer GmbH, Karlsruhe</source><year>2001</year></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>RJ</given-names></name><name><surname>Bennett</surname><given-names>S</given-names></name></person-group><article-title>Sample size calculation for cluster-randomized trials</article-title><source>Int J Epidemiol</source><year>1999</year><volume>28</volume><fpage>319</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">10342698</pub-id><pub-id pub-id-type="doi">10.1093/ije/28.2.319</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Shamash</surname><given-names>K</given-names></name><name><surname>Macdonald</surname><given-names>A</given-names></name><name><surname>Mann</surname><given-names>A</given-names></name></person-group><article-title>Randomised controlled trial of effect of intervention by psycho-geriatric team on depression in frail elderly people at home</article-title><source>British Medical Journal</source><year>1996</year><volume>313</volume><fpage>1058</fpage><lpage>1061</lpage><pub-id pub-id-type="pmid">8898601</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>MK</given-names></name><name><surname>Elbourne</surname><given-names>DR</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><article-title>CONSORT statement: extension to cluster randomised trials</article-title><source>BMJ</source><year>2004</year><volume>328</volume><fpage>702</fpage><lpage>708</lpage><pub-id pub-id-type="pmid">15031246</pub-id><pub-id pub-id-type="doi">10.1136/bmj.328.7441.702</pub-id></citation></ref><ref id="B22"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>A</given-names></name><name><surname>Steer</surname><given-names>R</given-names></name></person-group><article-title>Beck Depressions Inventar (BDI)</article-title><source>Bearbeitung der deutschen Ausgabe Hautzinger M, Bailer M, Worall H et Testhandbuch 2 Aufl, Huber Bern</source><year>1995</year></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moriskey</surname><given-names>D</given-names></name><name><surname>Green</surname><given-names>L</given-names></name><name><surname>Levine</surname><given-names>D</given-names></name></person-group><article-title>Current and predictive validity of a Self-reported measure of medication adherence</article-title><source>Medical Care</source><year>1986</year><volume>24</volume><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">3945130</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bullinger</surname><given-names>M</given-names></name><name><surname>Kirchberger</surname><given-names>I</given-names></name><name><surname>Ware</surname><given-names>J</given-names></name></person-group><article-title>Der deutsche SF-36 Health Survey</article-title><source>Übersetzung und psychometrische Testung eines krankheitsübergreifendes Instrumentes zur Erfassung der gesundheitsbezogenen Lebensqualität Zeitschrift für Gesundheitswissenschaften</source><year>1995</year><volume>1</volume><fpage>21</fpage><lpage>36</lpage></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><collab>EuroQOL-Group</collab></person-group><article-title>EuroQOL- a new facility for the measurement of health-related quality of life</article-title><source>Health Policy</source><year>1990</year><volume>16</volume><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">10109801</pub-id><pub-id pub-id-type="doi">10.1016/0168-8510(90)90421-9</pub-id></citation></ref></ref-list></back></article>